Industry News

Servier and miRagen Extend Collaboration for the Research, Development and Commercialization of microRNA-targeting Drugs for Cardiovascular Disease
Trevena Announces Positive Phase 1 Results for TRV734 for Acute and Chronic Pain
Curis Announces Investigational New Drug Application Filing by Roche to Initiate a Phase 2 Study of Erivedge(R) (vismodegib) in Idiopathic Pulmonary Fibrosis Filing Triggers $3 Million Milestone Payment to Curis
ANI Pharmaceuticals Inks Exclusive Pact with Dexcel Pharma Technologies
FDA Expands Testosterone Warning � National Attorneys Handling Androgel Lawsuits Provide New FDA Testosterone Warning Details at http://www.AndrogelTestosteroneLawsuitCenter.com
FDA approves Sivextro to treat skin infections
Drug Recall Attorney Jeffrey D. DeCarlo Comments on Voluntary Recall of 10,000 Allergy-Relief Medication Bottles
Teva Updates on U.S. Court of Appeals Uphold Ruling Confirming Invalidity of Baraclude Patent
Ocugen Receives Orphan Designation for OCU100 to Treat Retinitis Pigmentosa Ocugen, Inc.
Drugs firm Shire rejects GBP27bn US takeover offer
Kala Pharmaceuticals Initiates Phase 3 Clinical Trial for Treatment of Post-Surgical Ocular Inflammation and Phase 2 Clinical Trial in Dry Eye Disease
Teva Reaches Settlement in ProAir HFA Patent Case
Schumer: Amidst New Shortage of Vital Sterilization Product that Could Have Forced Surgeries at Syracuse Hospitals to Be Canceled, FDA Heeds...
Healthcare's next frontier
WuXi PharmaTech Toxicology Facility in Suzhou Passes FDA Inspection
Kala Pharmaceuticals Initiates Phase 3 Clinical Trial for Treatment of Post-Surgical Ocular Inflammation and Phase 2 Clinical Trial in Dry Eye Disease
MiMedx Expects To File Its First Investigational New Drug Application In July Company Adds Key Executives to Support its IND and BLA Initiatives
Breakthrough study sheds new light on best medication for children with seizures Clinical Trials and Studies
MiMedx Expects To File Its First Investigational New Drug Application In July Company Adds Key Executives to Support its IND and BLA Initiatives
MiMedx Expects To File Its First Investigational New Drug Application In July Company Adds Key Executives to Support its IND and BLA Initiatives
Manzo Pharmaceuticals announces the release of its newest product Tummy Relief a natural colic remedy for babies
FDA Accepts New Drug Application for Symplmed's Prestalia for the Treatment of Hypertension
Creation Technologies Receives FDA Registration for California Manufacturing Facility
FDA Accepts New Drug Application for Symplmed�s Prestalia� for the Treatment of Hypertension
Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine